We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approved Savella After Three-Month Delay Due to Whistle-Blower Allegation
FDA Approved Savella After Three-Month Delay Due to Whistle-Blower Allegation
January 23, 2009
Allegations from a whistle-blower regarding the integrity of the clinical study data supporting Forest Laboratories’ NDA for fibromyalgia drug Savella delayed agency approval of the product for nearly three months.